School of Medicine


Showing 301-310 of 507 Results

  • Derick Okwan

    Derick Okwan

    Assistant Professor of Pathology

    Current Research and Scholarly InterestsBroadly, the Okwan lab’s primary interest is to understand how and why the immune system contributes to nearly all chronic diseases. The immune system of the modern human has evolved from a history of stress to the species: famines, continual bouts of lethal pandemics, as well as major climate/environmental and migratory changes that exposed the immune system to novel threats. At the forefront of these challenges are innate immune cells, particularly neutrophils, the most abundant leukocytes. For the first time in human history – at least in the western world- we live in an era of abundance. The Okwan lab is interested in understanding how this traumatic history creates a functional mismatch for the neutrophil, which we believe underpins their roles in chronic diseases of the modern era: cancer, cardiovascular disease, neurodegeneration, and autoimmune disorders. Rather than wholesale depletion of neutrophils and innate immune cells, we seek to identify novel approaches to leverage these cells to combat various diseases.

  • Michael G. Ozawa

    Michael G. Ozawa

    Clinical Associate Professor, Pathology

    BioDr. Ozawa is a Clinical Associate Professor of Pathology with subspecialty focus in Cytopathology, Head and Neck pathology, and Thoracic pathology. He completed his M.D., Ph.D. training at the McGovern Medical School and the M. D. Anderson Cancer Center in Houston, TX. He then completed residency training in Anatomic and Clinical Pathology followed by fellowship training in Surgical Pathology and Cytopathology at Stanford University. He is board certified in Anatomic and Clinical Pathology as well as Cytopathology. His interests include pulmonary neoplasms as well as neoplasms of the Head and Neck. He also has developed collaborative research interests in utilizing fine needle aspiration (FNA) techniques in the growing clinical application of Chimeric Antigen T Cell (CAR-T) therapy.

  • Anil K. Panigrahi, MD, PhD, FASA

    Anil K. Panigrahi, MD, PhD, FASA

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
    Clinical Associate Professor (By courtesy), Pathology

    BioDr. Anil Panigrahi is a Clinical Associate Professor in the Departments of Anesthesiology and, by courtesy, Pathology at Stanford University School of Medicine. Dual board-certified in Anesthesiology and Blood Banking/Transfusion Medicine, he maintains active clinical practice in both fields. He serves as Director of Patient Blood Management at Stanford Health Care, Chair of the Stanford Health Care Transfusion Committee, Medical Director of the Anesthesiology Perioperative Anemia Management Clinic, and Assistant Medical Director of the Stanford Health Care Transfusion Service. His academic and clinical leadership focuses on advancing perioperative blood management strategies to optimize outcomes in complex surgical patients.

    A Phi Beta Kappa graduate of Duke University, Dr. Panigrahi received his M.D. and Ph.D. degrees from the University of Pennsylvania School of Medicine, where he was awarded the John G. Clark Prize for meritorious research. He completed residency training in Anesthesiology and fellowship in Blood Banking/Transfusion Medicine at Stanford University.

    Dr. Panigrahi’s scholarly work spans immunology, transfusion safety, and patient blood management. He has authored numerous peer-reviewed publications, textbook chapters, including for Miller’s Anesthesia and the AABB Technical Manual, and national guidelines. He contributes nationally through service on multiple committees for the American Society of Anesthesiologists (ASA) and the Association for the Advancement of Blood and Biotherapies (AABB), and he is a frequent invited speaker at national and international meetings, including those of the ASA, AABB, and Society for the Advancement of Patient Blood Management (SABM).